{"created":"2015-05-14T14:39:12+00:00","modified":"2015-05-14T14:39:12+00:00","valid":{"from":"2013-01-29T22:16:34+00:00","to":"3013-01-29T22:16:34+00:00"},"hreflang":"en","guid":"dcb85e72-cf9f-4e95-882b-f19daf53abd2","title":"FDA urges drug companies to make a safer pain killer","byline":"D Gorenstein","description":"With addiction to pain pills at epidemic levels, the Food and Drug Adminstration is taking action","itags":["PMP:Marketplace_PMP","Marketplace Morning Report for Wednesday, January 30, 2013","Marketplace","Marketplace Morning Report","dcb85e72cf9fe95382bbf19daf53abd2"],"contentencoded":"<div class=\"barn-cleaned\"><p>The Food and Drug Administration has a prescription painkiller epidemic on its hands. More than 16,000 people died in 2010 from overdosing on painkillers like OxyContin and Opana.</p>\n<p>That’s why the FDA is <a href=\"http://www.cnn.com/2013/01/25/health/hydrocodone-recommendation/index.html\" target=\"_blank\">considering a proposal</a> to restrict access to the drugs making it harder to get a prescription.</p>\n<p>But that’s just part of the plan to tackle the problem. The agency is playing a bigger role in the $8.5 billion dollar painkiller market, challenging the drug industry to build a painkiller that’s harder to abuse.</p>\n<p>“The federal government is going to be a player as never before in this market,” says Dan Carpenter, professor at Harvard University and author of the book \"<a href=\"http://www.amazon.com/Reputation-Power-Organizational-Pharmaceutical-International/dp/0691141800\" target=\"_blank\">Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA</a>.\"</p>\n<p>Historically, Carpenter says that once the agency approved drugs, it didn’t mettle after with them again. But, it’s different with painkillers. &nbsp;&nbsp;</p>\n<p>“The federal government is actively shaping the way in which the drug is consumed.”</p>\n<p>The FDA wants new drug formulations that make it very hard to get high, like pain pills you can’t crush into a powder to shoot or snort, as well as more rigorous, independent testing. &nbsp;&nbsp;</p>\n<p>The FDA is wading into the marketplace because addiction to painkillers, both prescribed and taken illegally, is soaring. &nbsp;</p>\n<p>IHS analyst Gustav Ando says the FDA is dangling a sweet carrot. “The rewards here are pretty big,” says Ando</p>\n<p>If a drug maker comes up with a tamper-proof drug, the FDA will label it \"proven to reduce abuse,\" which could lead to more prescriptions -- or as Ando says, gold.</p>\n<p>“Pharmaceutical companies really go where the money is,\" he explains. \"Providing the next generation painkiller -- you can’t ask for much more than that.”</p>\n<p>Right now, the painkiller market is dominated by generics. A new safer pill would let Big Pharma grab a chunk of that back.</p>\n<p>“This is one of these ironic circumstances, in which…the big line companies will actually do better, even though they are being heavily regulated,” says Harvard’s Dan Carpenter.</p>\n<p>Philadelphia doctor Aviva Fohrer treats opioid addicts. She likes the idea of a safer painkiller, but there are tradeoffs.</p>\n<p>“They’ll get a cheaper, easier drug, which is generally heroin. And the ramifications of that are it’s not produced by a pharmaceutical company. You don’t know what the doses are, you don’t know what’s in it,” Fohrer says.</p>\n<p>Fohrer points out the new generation of pills -- if developed -- are still dangerously addictive. That’s why the doctor says the solution has to be more than yet another pill, albeit one that’s harder to abuse.</p></div>","tags":["FDA","prescription","painkillers","APM","regulation","Business"],"teaser":"With addiction to pain pills at epidemic levels, the Food and Drug Adminstration is taking action","contenttemplated":"[{\"type\":\"text/html\",\"content\":\"<p>The Food and Drug Administration has a prescription painkiller epidemic on its hands. More than 16,000 people died in 2010 from overdosing on painkillers like OxyContin and Opana.</p>\"},{\"content\":\"<p>That’s why the FDA is <a href=\\\"http://www.cnn.com/2013/01/25/health/hydrocodone-recommendation/index.html\\\" target=\\\"_blank\\\">considering a proposal</a> to restrict access to the drugs making it harder to get a prescription.</p>\",\"type\":\"text/html\"},{\"content\":\"<p>But that’s just part of the plan to tackle the problem. The agency is playing a bigger role in the $8.5 billion dollar painkiller market, challenging the drug industry to build a painkiller that’s harder to abuse.</p>\",\"type\":\"text/html\"},{\"type\":\"text/html\",\"content\":\"<p>“The federal government is going to be a player as never before in this market,” says Dan Carpenter, professor at Harvard University and author of the book &quot;<a href=\\\"http://www.amazon.com/Reputation-Power-Organizational-Pharmaceutical-International/dp/0691141800\\\" target=\\\"_blank\\\">Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA</a>.&quot;</p>\"},{\"type\":\"text/html\",\"content\":\"<p>Historically, Carpenter says that once the agency approved drugs, it didn’t mettle after with them again. But, it’s different with painkillers.   </p>\"},{\"content\":\"<p>“The federal government is actively shaping the way in which the drug is consumed.”</p>\",\"type\":\"text/html\"},{\"content\":\"<p>The FDA wants new drug formulations that make it very hard to get high, like pain pills you can’t crush into a powder to shoot or snort, as well as more rigorous, independent testing.   </p>\",\"type\":\"text/html\"},{\"content\":\"<p>The FDA is wading into the marketplace because addiction to painkillers, both prescribed and taken illegally, is soaring.  </p>\",\"type\":\"text/html\"},{\"content\":\"<p>IHS analyst Gustav Ando says the FDA is dangling a sweet carrot. “The rewards here are pretty big,” says Ando</p>\",\"type\":\"text/html\"},{\"type\":\"text/html\",\"content\":\"<p>If a drug maker comes up with a tamper-proof drug, the FDA will label it &quot;proven to reduce abuse,&quot; which could lead to more prescriptions -- or as Ando says, gold.</p>\"},{\"content\":\"<p>“Pharmaceutical companies really go where the money is,&quot; he explains. &quot;Providing the next generation painkiller -- you can’t ask for much more than that.”</p>\",\"type\":\"text/html\"},{\"type\":\"text/html\",\"content\":\"<p>Right now, the painkiller market is dominated by generics. A new safer pill would let Big Pharma grab a chunk of that back.</p>\"},{\"type\":\"text/html\",\"content\":\"<p>“This is one of these ironic circumstances, in which…the big line companies will actually do better, even though they are being heavily regulated,” says Harvard’s Dan Carpenter.</p>\"},{\"type\":\"text/html\",\"content\":\"<p>Philadelphia doctor Aviva Fohrer treats opioid addicts. She likes the idea of a safer painkiller, but there are tradeoffs.</p>\"},{\"type\":\"text/html\",\"content\":\"<p>“They’ll get a cheaper, easier drug, which is generally heroin. And the ramifications of that are it’s not produced by a pharmaceutical company. You don’t know what the doses are, you don’t know what’s in it,” Fohrer says.</p>\"},{\"content\":\"<p>Fohrer points out the new generation of pills -- if developed -- are still dangerously addictive. That’s why the doctor says the solution has to be more than yet another pill, albeit one that’s harder to abuse.</p>\",\"type\":\"text/html\"}]","published":"2013-01-29T22:16:34+00:00","audio":[{"href":"http://www.marketplace.org/sites/default/files/styles/primary-image-610x340/public/678211.jpg?itok=mPf90pft","meta":{"width":"610","crop":"primary","height":"340"},"type":"image/jpeg"},{"meta":{"duration":148,"api":{"type":"application/json","href":"http://api.publicradio.org/audio/v2?ref=pmp&id=apm-audio:/marketplace/segments/2013/01/30/marketplace_segment05_20130130"},"duration_hms":"00:02:28"},"type":"audio/mpeg","format":"MP3","href":"http://play.publicradio.org/pmp/d/podcast/marketplace/segments/2013/01/30/marketplace_segment05_20130130_64.mp3"}]}